Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
Israel
Soroka Medical Center, Beersheba Hadassah Ein-Karem, Jerusalem Sheba Medical Center, Ramat Ef‘al Sourasky Tel Aviv Medical Center, Tel Aviv